Solace Therapeutics Inc — Form D
Solace Therapeutics Inc of FRAMINGHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-02-11. The offering totals $2.1M, of which $1.9M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-02-11
- Form: D
- Accession: 0001371796-19-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.1M
- Amount sold: $1.9M
- Remaining: $215K
- Investors: 6
- Date of first sale: 2019-01-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-332570
Issuer
- Name: Solace Therapeutics Inc
- CIK: 0001371796
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 135 NEWBURY STREET, FRAMINGHAM, MA, 01701
- Phone: 508-283-1200
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Ali G Behbahani | Director | Framingham, MA |
| Ryan G Drant | Director | Framingham, MA |
| Stacy G Enxing Seng | Director | Framingham, MA |
| John G McDonough | Director | Framingham, MA |
| Kevin G Connors | Executive Officer | Hopkinton, MA |
| Brian R Smith | Director | Austin, TX |
| William H Gruber | Director | Framingham, MA |
| William H Gruber | Executive Officer | Framingham, MA |
| John R McDonough | Director | Framingham, MA |
| David R Neustaedter | Director | Framingham, MA |
| Gerrit R Adams | Director | Framingham, MA |
| Kevin H Connors | Director | Woburn, MA |
| Kevin H Connors | Executive Officer | Woburn, MA |
| J. Daniel Cole | Director | Newton, MA |
| Dr. William Daniel Pintauro | Director | Framingham, MA |
| Kevin G Connors | Director | Hopkinton, MA |
Other filings by this issuer (4)
More